Charpentier J - Search Results

1

Infectious complications in out-of-hospital cardiac arrest patients in the therapeutic hypothermia era.

Mongardon N, Perbet S, Lemiale V, Dumas F, Poupet H, Charpentier J, Péne F, Chiche JD, Mira JP, Cariou A. Mongardon N, et al. Among authors: charpentier j. Crit Care Med. 2011 Jun;39(6):1359-64. doi: 10.1097/CCM.0b013e3182120b56. Crit Care Med. 2011. PMID: 21336107

2

[Role of host response during severe bacterial infection].

Charpentier J, Mira JP. Charpentier J, et al. Arch Pediatr. 2001 Sep;8 Suppl 4:689s-696s. doi: 10.1016/s0929-693x(01)80183-4. Arch Pediatr. 2001. PMID: 11582914 French.

3

The era of genomics: impact on sepsis clinical trial design.

Cariou A, Chiche JD, Charpentier J, Dhainaut JF, Mira JP. Cariou A, et al. Among authors: charpentier j. Crit Care Med. 2002 May;30(5 Suppl):S341-8. doi: 10.1097/00003246-200205001-00026. Crit Care Med. 2002. PMID: 12004257 Review.

4

Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome.

Dhainaut JF, Charpentier J, Chiche JD. Dhainaut JF, et al. Among authors: charpentier j. Crit Care Med. 2003 Apr;31(4 Suppl):S258-64. doi: 10.1097/01.CCM.0000057901.92381.75. Crit Care Med. 2003. PMID: 12682450 Review.

5

Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.

Dhainaut JF, Laterre PF, Janes JM, Bernard GR, Artigas A, Bakker J, Riess H, Basson BR, Charpentier J, Utterback BG, Vincent JL; Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Dhainaut JF, et al. Among authors: charpentier j. Intensive Care Med. 2003 Jun;29(6):894-903. doi: 10.1007/s00134-003-1731-1. Epub 2003 Apr 24. Intensive Care Med. 2003. PMID: 12712239 Clinical Trial.

6

Diagnosis and management of out-of-hospital cardiac arrest secondary to coronary artery spasm.

Meune C, Joly LM, Chiche JD, Charpentier J, Leenhardt A, Rozenberg A, Carli P, Sauval P, Weber S, Cracan A, Spaulding C. Meune C, et al. Among authors: charpentier j. Resuscitation. 2003 Aug;58(2):145-52. doi: 10.1016/s0300-9572(03)00149-7. Resuscitation. 2003. PMID: 12909376

7

Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis.

Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP, Chiche JD. Charpentier J, et al. Crit Care Med. 2004 Mar;32(3):660-5. doi: 10.1097/01.ccm.0000114827.93410.d8. Crit Care Med. 2004. PMID: 15090944

8

[Septic shock: new treatment].

Charpentier J, Cariou A. Charpentier J, et al. Rev Prat. 2004 Mar 15;54(5):475-6. Rev Prat. 2004. PMID: 15176502 Review. French. No abstract available.

9

[Can genetics guide or modify the management of severe sepsis?].

Mira JP, Charpentier J. Mira JP, et al. Among authors: charpentier j. Ann Fr Anesth Reanim. 2003 Dec;22 Spec No 1:48-52. Ann Fr Anesth Reanim. 2003. PMID: 15359945 Review. French. No abstract available.

10

Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway.

Adrie C, Monchi M, Laurent I, Um S, Yan SB, Thuong M, Cariou A, Charpentier J, Dhainaut JF. Adrie C, et al. Among authors: charpentier j. J Am Coll Cardiol. 2005 Jul 5;46(1):21-8. doi: 10.1016/j.jacc.2005.03.046. J Am Coll Cardiol. 2005. PMID: 15992630 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page